SNGX Stock | News | Quote | Stock Forum | Saturday, October 26,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Soligenix, Inc. SNGX Company Overview 

Stock Message Board http://investorshangout.com/search?q=SNGX&...mp;yt1=Go!

Last Updated: Saturday, October 26, 2013 02:26:34 AM

Soligenix, Inc. SNGX Current Price and Quotes
Last Price 2.01
Previous Close 2.05 Open 2.05
Daily Range 2.12 - 2.00 52wk Range 2.48 - 0.43
Volume 22,688 Dividend N/A
Average Vol (3m) 82,448 Yield N/A
Soligenix, Inc. SNGX
Company Information

29 Emmons Drive
Suite C-10
Princeton, NJ 08540

Website: http://www.soligenix.com
Phone: 609-538-8200

Soligenix, Inc. SNGX
Soligenix, Inc. is a development stage biopharmaceutical company committed to developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Soligenix has two areas of focus: 1) a therapeutics segment dedicated to the development of products for orphan diseases and areas of unmet medical need such as oral mucositis, pediatric Crohn's disease, acute radiation enteritis, and Graft-versus-Host dis...



Soligenix, Inc. SNGX
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0000812796
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Jun 10, 2013
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Christopher J. Schaber President, CEO
Joseph M. Warusz Vice President, Acting CFO, Principal Acct. Officer
Company Directors

Keith Brownlie
Gregg Lapointe
Robert Rubin
Jerome Zeldis
Company Notes

Formerly=DOR BioPharma, Inc. until 9-2009
Formerly=Endorex Corp. until 12-01
Formerly=ImmunoTherapeutics, Inc. until 9-96
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Soligenix, Inc. SNGX
SNGX Security Details

Share Structure

Market Value1 $38,251,279 a/o Oct 25, 2013
Shares Outstanding 19,030,487 a/o Aug 07, 2013
Float Not Available
Authorized Shares 50,000,000 a/o Jun 07, 2013
Par Value  0.001
Shareholders

Shareholders of Record 940 a/o Feb 26, 2013
Security Notes

New Issue=6-87 500,000 shs in units (1 sh Com & 1 Class A Warr 7-31-92) at $4 per unit by Seaboard Planning Corp.
Note=4-18-06 deleted from AMEX
Capital Change=shs decreased by 1 for 15 split Pay date=06/11/1997.
Capital Change=shs decreased by 1 for 20 split. Pay date=02/01/2012.
Short Selling Data

Short Interest 358,964 (3.8%)
Sep 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

American Stock Transfer & Trust Company

Soligenix, Inc. SNGX Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 3,145 7,663 1,948 2,816
Cost of Revenue 2,593 2,108 1,638 1,484
Gross Profit 552 5,555 309 1,332
Operating Expenses

Research and Development 2,609 6,273 5,986 4,523
Sales, General and Admin. 2,633 2,242 2,201 2,860
Non-Recurring Items - - - -
Other - - - -
Operating Income (4,691) (2,960) (7,878) (6,051)
Income From Continuing Operations

Add'l Income/Expense Items 6 7 247 20
Earnings Before Interest and Tax (4,684) (2,953) (7,632) (6,032)
Interest Expense - - 1 3
Earnings Before Tax (4,684) (2,953) (7,632) (6,034)
Income Tax (521) (574) (246) -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (4,163) (2,379) (7,387) (6,034)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (4,163) (2,379) (7,387) (6,034)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (4,163) (2,379) (7,387) (6,034)

Soligenix, Inc. SNGX Recent News

Oct 21, 2013 Soligenix Announces Appointment of Marco Maria Brughera to its Board of Directors
Oct 17, 2013 Soligenix Announces Formation of International Melioidosis Scientific Advisory Board
Oct 3, 2013 Soligenix Appoints Oreola Donini, PhD, as Vice President of Preclinical Research and Development
Sep 25, 2013 Soligenix Awarded NIAID Contract Valued up to $6.4 Million for the Development of OrbeShield(TM) in GI ARS
Sep 19, 2013 Soligenix Awarded BARDA Contract Valued up to $26.3 Million for Advanced Development of OrbeShield(TM) in GI ARS
Sep 16, 2013 FDA Grants Soligenix Orphan Drug Designation for SGX94 for Treatment of Acute Radiation Syndrome
Sep 5, 2013 Soligenix to Present at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City
Aug 12, 2013 Soligenix Reports Second Quarter 2013 Financial Results, and Highlights Recent Accomplishments


SNGX Soligenix, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=SNGX&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/SNGX/quote
Stock Chart http://www.otcmarkets.com/stock/SNGX/chart
Company Info http://www.otcmarkets.com/stock/SNGX/company-info
Recent News http://www.otcmarkets.com/stock/SNGX/news
Financials http://www.otcmarkets.com/stock/SNGX/financials
Filings and Disclosure http://www.otcmarkets.com/stock/SNGX/filings
Short Sales http://www.otcmarkets.com/stock/SNGX/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/SNGX/insider-transactions
Research Reports http://www.otcmarkets.com/stock/SNGX/research
Summary http://finance.yahoo.com/q?s=SNGX
Historical Prices http://finance.yahoo.com/q/hp?s=SNGX+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=SNGX
Basic Chart http://finance.yahoo.com/q/bc?s=SNGX+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=SNGX+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=SNGX+Headlines
Press Releases http://finance.yahoo.com/q/p?s=SNGX+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=SNGX+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=SNGX+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=SNGX+Industry
Major Holders http://finance.yahoo.com/q/mh?s=SNGX+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=SNGX+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=SNGX+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=SNGX
Balance Sheet http://finance.yahoo.com/q/bs?s=SNGX
Cash Flow http://finance.yahoo.com/q/cf?s=SNGX+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/SNGX
Market Watch http://www.marketwatch.com/investing/stock/SNGX
Bloomberg http://www.bloomberg.com/quote/SNGX:US
Morningstar http://quotes.morningstar.com/stock/s?t=SNGX
Bussinessweek http://investing.businessweek.com/research/st...icker=SNGX
Barchart http://www.barchart.com/quotes/stocks/SNGX
OTC Short Report http://otcshortreport.com/index.php?index=SNGX
Investopedia http://www.investopedia.com/markets/stocks/SNGX/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Singapore's New Leap in Healthcare Innovation with IMDA-NUH Partnership

Updated Category News Views 24

A Groundbreaking Partnership in Singapore's Healthcare Sector Every so often, something big comes along that makes you stop and take notice. This time, it's the alliance between the Infocomm Media Development Authority (IMDA) and the National University Hospital (NUH) in Singapore. By launching an Open Innovation Platform (OIP) partnership, they've embarked on a journey...

Continue Reading
Western Microsurgical Expands Through Strategic Acquisitions

Updated Category News Views 95

Western Microsurgical's Bold Moves Western Microsurgical (WMS) is out here making waves, pulling off some serious strategic plays with the acquisitions of Q Surgical and Proficient Surgical. Now, this ain't some fly-by-night decision—this is about securing territory and leveling up their game in surgical microscopes and operating room supplies. With a footprint that'll...

Continue Reading
Local Expertise Key in Navigating Tahoe Real Estate

Updated Category News Views 105

Diving Into Tahoe's Unique Real Estate Scene If you think all real estate markets sing the same tune, take a stroll through South Lake Tahoe's offerings, and you'll find yourself singing a different song. Buying property in this neck of the woods requires more than a keen eye for granite countertops or a Zillow addiction. It demands a local guide—someone who knows the...

Continue Reading
Lynk Pharmaceuticals' Zemprocitinib Shines in Phase III RA Trial

Updated Category News Views 112

A Deep Dive into Lynk Pharmaceuticals' Latest Revelation Lynk Pharmaceuticals just dropped a bombshell with their latest Phase III trial results for zemprocitinib. This selective JAK1 inhibitor seems to be bringing some serious game in the fight against moderate-to-severe rheumatoid arthritis (RA), especially for folks who haven't had much luck with biologics. The drug...

Continue Reading
Etisalat Surges: Net Profit Soars 46% Amid Growth

Updated Category News Views 147

Etisalat's Stellar Performance: A Deeper Dive When a company like Etisalat drops news of a whopping 46% increase in net profit year-over-year, you sit up and pay attention. Those numbers aren’t just a flash in the pan; they're the result of some serious strategic maneuvers and ripe market conditions. Etisalat isn't resting on its laurels, and their latest financials...

Continue Reading
Endava Faces Class Action: Investors Eye Their Next Move

Updated Category News Views 52

A Mess That Investors Can't Ignore If you're holding onto Endava plc shares, you've probably felt that gut-punch lately. Yeah, things are getting heated with a class action lawsuit alleging the company played fast and loose with its accounting practices. The complaint's about some shady dealings that may have thrown off investors' perceptions. The Core Allegations This...

Continue Reading
Brinker International Posts Solid Q1 2027 Earnings

Updated Category News Views 15

Strong Earnings Highlight a Winning Streak Brinker International, folks, has done it again. With the latest release of their first quarter fiscal 2027 results, it’s clear they’ve been hitting the right notes, especially at Chili’s. The numbers don't lie—trust me, I've seen my fair share of earnings calls, and this one's got meat on the bones. Let’s break it...

Continue Reading
Corgi Insurance Eyes $100B Auto Market with New Launch

Updated Category News Views 93

Leaping Into a Booming Market Well, it looks like someone lit a fire under Corgi Insurance, and they're ready to chase bigger bones. They’ve just rolled out a product called Corgi Business Auto, signaling quite a bold move into the hefty, nearly $100 billion U.S. commercial auto insurance arena. Now, as an old hand at this game, my ears perk up whenever I see a player...

Continue Reading
Navigating Home Care: What Families Need to Know

Updated Category News Views 94

Peeking into the Home Care Playbook The process of starting home care isn't some mind-boggling puzzle. For families in Northeastern Pennsylvania, things kick off with a cordial chinwag with a care coordinator—no paperwork chains or Kafkaesque contracts right off the bat. Now, if you've got someone in need of care, this gives you time to shove all your questions onto the...

Continue Reading
CPSC's Battle Against Dangerous Imports Intensifies

Updated Category News Views 0

Feldman Sounds Alarm at Bangkok Conference Imagine the chaos if safety took a back seat in our daily lives. Well, that's exactly what's at stake with the influx of dangerous consumer products sailing into our markets. Acting Chairman of the U.S. Consumer Product Safety Commission (CPSC), Peter A. Feldman, gave a no-holds-barred speech on this matter at the INTERPOL...

Continue Reading

Top 5 Most Recently Viewed Articles

BellRing Brands (NYSE: BRBR) Faces Investigation Over Fraud Claims

Updated Category News Views 124

BellRing Brands Under Investigation Recently, it has come to light that BellRing Brands, Inc. (NYSE: BRBR) is facing an intense investigation concerning potential securities fraud. This inquiry is spearheaded by the prominent securities law firm Bleichmar Fonti & Auld LLP, which is examining the company for possible violations of federal securities laws. For those who...

Continue Reading
SQAIRZ Unveils New Era in Pickleball Footwear with Zane Navratil

Updated Category News Views 625

Exciting News from SQAIRZ: Zane Navratil Joins the Team SQAIRZ, known for its innovative approach to athletic footwear, is proud to announce the latest addition to its team: Zane Navratil, a celebrated figure in the world of pickleball. As a multiple-time champion, Zane brings a wealth of knowledge and experience to SQAIRZ, playing a key role in the development of the...

Continue Reading
Stem Inc. Welcomes New CTO to Propel AI Innovation Forward

Updated Category News Views 108

Stem Inc. Appoints Dr. Albert Hofeldt as New CTO SAN FRANCISCO - Stem Inc. (NYSE: STEM), a leading company in AI-enabled clean energy software and services, has elevated Dr. Albert Hofeldt to the role of Chief Technology Officer (CTO). This significant move aims to strengthen the company's technological front through innovative software solutions. Dr. Hofeldt's Role in...

Continue Reading
Discover October’s Top Investment Picks for Savvy Investors

Updated Category News Views 106

Understanding the MarketRank Tool for Stock Insights For investors seeking valuable insights, tools like the MarketRank™ feature by MarketBeat are indispensable. This tool compiles data for over 1.5 million stock listings globally, categorizing them across eight distinct areas. Its scoring system ranks stocks from one to five, with a Five Star rating highlighting those...

Continue Reading
Equinox Gold Earnings on Deck: EPS Insights and Trader Vibes

Updated Category News Views 116

Equinox Gold (AMEX:EQX) is set to drop its quarterly earnings on February 18, 2026, and you better believe traders are locked in. The buzz around this release isn’t just idle chatter; it's the kind that moves markets. Analysts are pegging the earnings per share (EPS) at a neat $0.21. Yeah, you heard right—$0.21 could make or break sentiment here. EPS Expectations:...

Continue Reading